Analyst Ratings for Achilles Therapeutics (ACHL)

ACHL Rating Summary

  |   Expand Research on ACHL
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 80%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/5/2024 Piper Sandler Joseph Catanzaro Downgrade Neutral
(Overweight)		 2.00
(8.00)		 1.20
(1.48)		 23.33% Details
12/14/2023 BofA Securities Tazeen Ahmad Downgrade Underperform
(Buy)		 0.50
(7.00)		 0.96
(1.48)		 54.17% Details